Skip to content
Research/Longevity Anti Aging/Niagen (Nicotinamide Riboside)

Niagen (Nicotinamide Riboside)

NAD+ precursor that converts to NMN then NAD+. Clinically shown to increase NAD+ levels by ~60% in humans. Reduces arterial stiffness, neuroprotective. Brand name: Tru Niagen.

Intelligence Profile

Clinical Applications

Nicotinamide riboside (NR) is being investigated for several therapeutic applications, primarily focused on conditions involving mitochondrial dysfunction and metabolic disorders.

Cardiovascular Health

A completed Phase 1/2 clinical trial (NCT03423342) examined NR in systolic heart failure patients, though specific outcomes from this study are not detailed in the available evidence.

Metabolic Disorders

Clinical research has explored NR's effects on metabolic health (NCT02835664), with particular attention to its role in NAD+ homeostasis. Recent preclinical evidence suggests that glucocorticoid excess can disrupt NAD+ balance in both male and female mice, indicating potential applications for metabolic conditions involving steroid dysfunction.

Exercise and Physical Performance

A completed study (NCT04907110) investigated NR supplementation in conjunction with exercise, and another trial (NCT03432871) examined its effects on mitochondrial biogenesis, suggesting potential applications for enhancing physical performance and cellular energy metabolism.

Neuromuscular and Inflammatory Conditions

Emerging preclinical evidence indicates NR may have therapeutic potential for:

  • Neuromuscular disorders: Research shows NR can prevent mitochondrial dysfunction in nemaline myopathy type 6, a rare muscle disorder
  • Neuroinflammation: Studies demonstrate NR reduces glial inflammation while boosting mitochondrial function
  • Psoriasis: Recent findings suggest NAD+ augmentation through NR may attenuate inflammatory responses by engaging specific cellular signaling pathways

Current Research Limitations

The clinical evidence for NR remains limited, with most completed trials lacking published outcome data in the available literature. Much of the mechanistic understanding comes from preclinical studies in cell cultures and animal models. An ongoing study (NCT06919328) is examining injectable forms of NR, which may provide new insights into optimal delivery methods.

Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider before considering NR supplementation for any medical condition.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.